Scarica l'app Stockscreener
2.90
1.02%
-0.03
Pre-mercato:
2.97
0.07
+2.41%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Altimmune Inc Borsa (ALT) Ultime notizie
Here's why you should add Altimmune stock to your portfolio now - MSN
Altimmune's Q1 loss narrower than expected, revenues nil - MSN
Here's Why You Should Add Altimmune Stock to Your Portfolio Now - Yahoo Finance
Altimmune Q3 2025 Earnings Preview - MSN
ALT Stock Price, Quote & Chart | ALTIMMUNE INC (NASDAQ:ALT) - ChartMill
H.C. Wainwright cuts Altimmune stock price target on dilution - Investing.com India
H.C. Wainwright cuts Altimmune stock price target on dilution By Investing.com - Investing.com South Africa
H.C. Wainwright Maintains Altimmune(ALT.US) With Buy Rating, Maintains Target Price $20 - Moomoo
Several Insiders Invested In Altimmune Flagging Positive News - simplywall.st
ALT Maintained by HC Wainwright & Co. -- Price Target Lowered to $20 - GuruFocus
H.C. Wainwright Maintains Altimmune(ALT.US) With Buy Rating, Cuts Target Price to $20 - Moomoo
Altimmune Price Target Cut to $20.00/Share From $25.00 by HC Wainwright & Co. - Moomoo
Altimmune Inc Price USD, ALT Price Live Charts, Market Cap & News - Bitget
ALT: Altimmune Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Altimmune Inc (ALT) Stock Price, Quote, News & History - Benzinga
Tang Capital (ALT) reports 666,022 shares, 0.3% stake in Altimmune (ALT) - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
ALT Maintained by Citizens -- Price Target Lowered to $11.00 - GuruFocus
Altimmune Is Maintained at Market Outperform by Citizens - Moomoo
Truist Financial Maintains Altimmune(ALT.US) With Buy Rating - Moomoo
Altimmune's Q1 Loss Narrower Than Expected, Revenues Nil - The Globe and Mail
Altimmune heads to Barcelona for EASL26 to engage global liver disease specialists - Traders Union
A Quick Look at Today's Ratings for Altimmune(ALT.US), With a Forecast Between $11 to $20 - Moomoo
Citizens cuts Altimmune stock price target on increased share count By Investing.com - Investing.com Nigeria
Altimmune, Inc. (NASDAQ:ALT) Q1 2026 Earnings Call Transcript - Insider Monkey
Altimmune shares rise over 3% on beating first quarter loss estimates - Investing.com
Citizens cuts Altimmune stock price target on increased share count - Investing.com
2.98%
1.33%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):